Caplin Point Laboratories Ltd CAPLIPOINT-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 1:44 PM IST
462.55quote price arrow down-4.35 (-0.93%)
Volume
65,917
52 week range
176.20 - 686.00

...

Loading . . .

KEY STATS

  • Open470.00
  • Day High471.40
  • Day Low457.10
  • Prev Close466.90
  • 52 Week High686.00
  • 52 Week High Date08/07/20
  • 52 Week Low176.20
  • 52 Week Low Date03/24/20
  • Market Cap476.14M
  • Shares Out75.64M
  • 10 Day Average Volume153,681.1
  • Dividend2.50
  • Dividend Yield0.54%
  • Beta
  • 1 Year % Change53.67

RATIOS/PROFITABILITY

  • EPS (TTM)29.71
  • P/E (TTM)15.57
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/21/2020
  • Div Amount0.40
  • Split Date-
  • Split Factor-

Latest Caplin Point Laboratories Ltd News

There is no recent news for this security.

Latest CAPLIPOINT-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers. The Company offers a range of products, including Tablets, Liquid Orals, Capsule, Softgel Capsules, Suppositories and Ovules, Powder for Injection, Dry syrup, Topicals, Liquid Injections, Inhalers, intravenous (IV) Infusion, Lyophilized Products, Branded Products, Dermo...
C. Paarthipan
Non-Executive Chairman
Vivek Siddharth
Chief Operating Officer
D. Muralidharan
Chief Financial Officer
Address
NARBAVI
No. 3, Lakshmanan Street, T. Nagar
Chennai
600017
India